TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Investor Investigation In Connection With March 18, 2015 Secondary Offering Announced

  • If you purchased shares of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) in the March 18, 2015 Secondary Offering at $199.00 per share, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

April 1, 2016 (Shareholders Foundation) - An investigation on behalf of investors, who purchased shares ofValeant Pharmaceuticals Intl Inc (NYSE:VRX) in the March 18, 2015 Secondary Offering at $199.00 per share, was announced concerning over potential securities laws violations in connection with the March 18, 2015 Secondary Offering. Shares of Valeant Pharmaceuticals Intl Inc (NYSE...



You must register (for free) or login to view the entire investigation.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: